Nano-Drug Delivery Systems in Oral Cancer Therapy: Recent Developments and Prospective
Yun Zhang,
No information about this author
Yongjia Wu,
No information about this author
Hongjiang Du
No information about this author
et al.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
16(1), P. 7 - 7
Published: Dec. 19, 2023
Oral
cancer
(OC),
characterized
by
malignant
tumors
in
the
mouth,
is
one
of
most
prevalent
malignancies
worldwide.
Chemotherapy
a
commonly
used
treatment
for
OC;
however,
it
often
leads
to
severe
side
effects
on
human
bodies.
In
recent
years,
nanotechnology
has
emerged
as
promising
solution
managing
OC
using
nanomaterials
and
nanoparticles
(NPs).
Nano-drug
delivery
systems
(nano-DDSs)
that
employ
various
NPs
nanocarriers
have
been
extensively
developed
enhance
current
therapies
achieving
controlled
drug
release
targeted
delivery.
Through
searching
analyzing
relevant
research
literature,
was
found
certain
nano-DDSs
can
improve
therapeutic
effect
drugs
enhancing
accumulation
tumor
tissues.
Furthermore,
they
achieve
through
adjustments
particle
size,
surface
functionalization,
encapsulation
technology
nano-DDSs.
The
application
provides
new
tool
strategy
therapy,
offering
personalized
options
patients
delivery,
reducing
toxic
effects,
improving
outcomes.
However,
use
therapy
still
faces
challenges
such
toxicity,
precise
targeting,
biodegradability,
satisfying
drug-release
kinetics.
Overall,
this
review
evaluates
potential
limitations
different
focusing
their
components,
mechanisms
action,
laboratory
aiming
provide
insights
into
understanding,
designing,
developing
more
effective
safer
Future
studies
should
focus
addressing
these
issues
further
advance
development
therapy.
Language: Английский
Therapeutic potential of ursolic acid (UA) and their derivatives with nanoformulations to combat nosocomial pathogens
Future Journal of Pharmaceutical Sciences,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: March 11, 2025
Abstract
Background
Ursolic
acid
(UA)
is
a
natural
pentacyclic
triterpene
derived
from
fruit,
herbs,
and
other
plants
of
the
terpenoid
category.
UA
has
multi-dynamic
antimicrobial
activity
against
various
pathogens.
However,
its
poor
water
solubility,
low
intestinal
mucosal
absorption,
bioavailability
restrict
clinical
application.
Nanotechnology
can
overcome
these
deficiencies
with
nanoformulations:
nanoemulsion,
nanoparticles,
nanoemulgels,
liposomes,
supramolecular
gel.
derivatives
are
used
as
therapeutic
agents
have
immunomodulatory
functions.
The
main
body
abstract
Nanoformulations
popularly
known
promising
delivery
system
for
several
drugs
to
increase
their
efficacy.
act
on
many
cellular
targets
such
bacterial
cell
envelop,
efflux
pump,
enzymatic
inhibition,
microbial
(fungal
virus)
virulence
factors,
demonstrating
that
it
be
potential
biomedicinal
agent
antibacterial,
antifungal,
antiviral
activity.
Various
nanoformulations
been
reported
decrease
MIC
available
nosocomial
pathogens
Staphylococcus
aureus,
Escherichia
coli,
Streptococcus
pneumoniae,
Klebsiella
Pseudomonas
aeruginosa.
Short
conclusion
This
review
highlights
traditional
modern
extraction
purification
techniques.
also
focuses
pharmaceutical
uses
treat
different
types
infections.
Further,
UA’s
comprehensive
molecular
mechanism
discussed.
Language: Английский
Effects of ursolic acid on growth performance, serum biochemistry, antioxidant capacity, and intestinal health of broilers
X.W. Zhang,
No information about this author
X. Li,
No information about this author
Yulong Yin
No information about this author
et al.
animal,
Journal Year:
2024,
Volume and Issue:
19(1), P. 101385 - 101385
Published: Nov. 28, 2024
Previous
studies
have
shown
that
adding
450
mg/kg
of
ursolic
acid
(UA)
can
improve
the
growth
performance
broilers.
However,
specific
mechanism
is
still
unclear.
Therefore,
purpose
this
study
was
to
further
explore
whether
UA
promotes
broilers
by
affecting
intestinal
environment
We
randomly
divided
120
with
similar
BW
(46.53
±
0.05
g)
into
two
groups.
Each
group
had
six
replicates,
10
per
replicate.
The
were
fed
either
corn-soybean
meal-basal
diet
(CON
group)
or
supplemented
(UA
group).
This
lasted
42
days.
Adding
increased
daily
weight
gain
and
feed
conversion
ratio
(P
<
0.05).
exhibited
reduced
aspartate
aminotransferase,
total
cholesterol,
interleukin
6
1,
triacylglycerol
levels,
high-density
lipoprotein
cholesterol
in
serum
supplementation
improved
antioxidant
capacity,
superoxide
dismutase,
glutathione
peroxidase
activity
0.05),
these
levels
jejunum
It
malondialdehyde
concentration
ileum
jejunal
morphology
increasing
villus
height
villus-to-crypt
ratio,
decreased
crypt
depth
Gene
expression
zona
occludens
1
Claudin-1
higher,
while
lower
Additionally,
gene
mucosa
higher
Significant
differences
observed
abundance
Bacteroides,
proteobacteria,
desulfurisation
bacteria
Barnesiella
Clostridia_UCG-014,
Romboutsia
negatively
correlated
6,
triacylglycerol,
but
positively
In
conclusion,
broiler
reduce
ileal
inflammation,
morphology,
regulate
caecal
microbiota
structure
composition,
promoting
growth.
Language: Английский
Ursolic Acid-Loaded Chitosan Nanoparticles Modulate the Expression Pattern of Apoptotic Markers Towards Oral Tumour Inhibition in Golden Syrian Hamsters
Mohan Karthik,
No information about this author
Ellapan Paari,
No information about this author
S Sivasankaran
No information about this author
et al.
Tropical Journal of Natural Product Research,
Journal Year:
2023,
Volume and Issue:
7(11)
Published: Dec. 1, 2023
Apoptosis,
a
systematic
and
harmonized
sequential
process,
eliminates
cells
that
contain
potentially
dangerous
mutations.
Cancer
evade
apoptosis
by
interfering
with
the
functions
of
pro-apoptotic
anti-apoptotic
proteins.
The
efficiency
ursolic
acid-loaded
chitosan
nanoparticles
(UACNP)
in
modulating
markers’
expression
towards
tumor
inhibition
was
assessed
using
immunohistochemistry
7,12-
dimethylbenz(a)anthracene
(DMBA)-induced
oral
carcinoma
golden
Syrian
hamsters.
An
developed
buccal
pouch
hamsters
painting
DMBA,
three
times
perweek
for
14
weeks.
While
mucosa
mutant
p53
Bcl-2
proteins
were
overexpressed,
Bax,
Bid,
Bad,
caspase-3
9
downregulated
tumor-bearing
UACNP
administration
(12.5
mg/Kg
b.w)
to
hamsters,
on
alternative
days
DMBA
exposure
reverted
immunoexpression
pattern
apoptotic
markers
formation.
present
investigation
also
observed
can
improve
marker
chemotherapeutic
phase
(DMBA
→
UACNP)
as
evidenced
reduction
number
tumors
well
size.
findings
thus
highlight
UACNP,
which
could
probably
be
attributed
its
tumor-preventing
efficacy
DMBA-induced
carcinogenesis. 
Language: Английский